- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-functional Binders)(Non-covalent)
MG.2: 1 residues within 4Å:- Ligands: ANP.1
No protein-ligand interaction detected (PLIP)MG.3: 4 residues within 4Å:- Chain A: R.140, K.144, R.151
- Ligands: ANP.1
No protein-ligand interaction detected (PLIP)MG.11: 1 residues within 4Å:- Ligands: ANP.10
No protein-ligand interaction detected (PLIP)MG.12: 2 residues within 4Å:- Chain B: R.140
- Ligands: ANP.10
No protein-ligand interaction detected (PLIP)- 2 x 86X: 6-chloranyl-7-fluoranyl-3-[3-[(2R)-3-oxidanylidenepiperidin-2-yl]propyl]quinazolin-4-one(Non-covalent)
86X.4: 14 residues within 4Å:- Chain A: F.85, E.88, V.89, P.108, T.109, E.111, R.140, W.157, F.204, T.228, H.230, W.259, G.260
- Ligands: ANP.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:P.108, A:T.109, A:W.157, A:F.204
- Hydrogen bonds: A:T.109
- Water bridges: A:R.140
- pi-Stacking: A:F.85, A:F.85
86X.13: 15 residues within 4Å:- Chain B: F.85, E.88, V.89, P.108, T.109, E.111, R.140, W.157, F.204, T.228, H.230, S.258, W.259, G.260
- Ligands: ANP.10
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:P.108, B:T.109, B:W.157, B:F.204, B:T.228
- Hydrogen bonds: B:T.109, B:T.109
- Water bridges: B:R.140, B:T.228
- pi-Stacking: B:F.85, B:F.85
- 5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 3 residues within 4Å:- Chain A: E.46, K.47, R.50
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.47
EDO.6: 3 residues within 4Å:- Chain A: F.51, E.187, R.284
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.187, A:E.187
EDO.7: 6 residues within 4Å:- Chain A: E.197, I.470, P.471, F.472, Q.474, R.492
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.197, A:E.197, A:R.492
EDO.14: 2 residues within 4Å:- Chain B: R.252, L.253
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.252, B:L.253
- Water bridges: B:L.253
EDO.15: 6 residues within 4Å:- Chain A: L.100, P.101, I.104
- Chain B: D.30, I.31, S.32
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.30, B:S.32
- Water bridges: B:W.141, B:R.153
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.9: 1 residues within 4Å:- Chain A: F.143
Ligand excluded by PLIPCL.16: 2 residues within 4Å:- Chain B: M.387, E.388
Ligand excluded by PLIPCL.17: 2 residues within 4Å:- Chain B: Q.289, D.320
Ligand excluded by PLIPCL.18: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain B: E.46, K.47
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jain, V. et al., Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. Structure (2017)
- Release Date
- 2018-03-07
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-functional Binders)(Non-covalent)
- 2 x 86X: 6-chloranyl-7-fluoranyl-3-[3-[(2R)-3-oxidanylidenepiperidin-2-yl]propyl]quinazolin-4-one(Non-covalent)
- 5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jain, V. et al., Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. Structure (2017)
- Release Date
- 2018-03-07
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D